Thom has 7 years of consultancy experience in raising funding for biopharmaceutical and medtech companies as advisor for Catalyze, Health-Holland and FFUND. In these functions Thom was involved in raising over €85 million non-dilutive capital and has developed in-depth knowledge on a wide range of topics in Life Sciences (including ATMPs, small molecules, Medical Devices (class I, II and III) and IVDs). In addition, he was the CEO of 2ndB, an Organ-on-Chip start-up focused on creating neuron-based-networks using microfluidics for the pre-clinical prediction of efficacy for Parkinsons Disease therapeutics. Thom has a BSc and MSc in Science and Innovation Management at Utrecht University. In 2023, Thom has completed his MBA with great distinction (magna cum laude) at the Vlerick Business School in Belgium.